Beta
Back to PFE.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • PEG Ratio
  • EPS Surprise %
  • Revenue Surprise %
peg-ratio-chart

PFE PEG Ratio

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for Pfizer's (PFE) PEG Ratio in Q4'25 stands at 0.15, reflecting a modest positive valuation relative to earnings growth, following a value of 0.44 in Q3'25. This marks an improvement from the negative territory observed in prior periods, though it remains below the 1.0 threshold often considered indicative of fair value. Over the period from Q1'23 to Q4'25, the PEG Ratio has exhibited high volatility, starting at 1.04 in Q1'23 before plunging to -0.38 in Q2'23 and fluctuating through negative values, including a sharp drop to -16.78 in Q2'24, with Q1'25 and Q2'25 showing no data. Notable inflection points include a brief recovery to near-zero in Q3'24 (0.00) and a return to positive territory in Q3'25, suggesting unstable market perceptions of growth prospects amid the area chart's depiction of erratic trends rather than sustained growth or decline.